RNA interference appears as a promising tool for therapeutic gene silencing. A key limit is the delivery of the siRNA. A safe approach is to use a physical method such as in vivo electropulsation with contact electrodes. Getting a long lived silencing can be better approached by using the in situ expression of shRNA. This is presently obtained by using co-electrotransfer of specific plasmids coding for expression and silencing of a fluorescent protein. Using a non invasive fluorescence imaging assay, electrodelivery in mouse muscles is observed to induce complete silencing over more than two months in a specific way. The proper choices of the plasmids (sequence and relative amounts) and of the electric pulsing conditions appear as key parameters in the successful silencing.
ChengJ. C.MooreT. B.SakamotoK. M.RNA interference and human disease. Molecular Genetics and Metabolism80, 121–128 (2003).
2.
DykxhoornD. M.NovinaC. D.SharpP. A.Killing the messenger: Short RNAs that silence gene expression. Nature Reviews Molecular Cell Biology4, 457–467 (2003).
3.
WaltersD. K.JelinekD. F.The effectiveness of double-stranded short inhibitory RNAs (siRNAs) may depend on the method of transfection. Antisense Nucleic Acid Drug Development12, 411–418 (2002).
4.
ElbashirS. M.LendeckelW.TuschlT.RNA interference is mediated by 21 and 22 nucleotides RNAs. Genes Development15, 188–200 (2001).
5.
ElbashirS. M.HarborthJ.LendeckelW.YalcinA.WeberK.TuschlT.Duplexes of 21 nucleotides RNAs mediate RNA interference in cultured mammalian cells. Nature411, 494–498 (2001).
6.
GolzioM.MazzoliniL.MollerP.RolsM. P.TeissieJ.Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery. Gene Therapy12, 246–251 (2005).
7.
ContrerasJ. L.VilatobaM.EcksteinC.BilbaoG.ThompsonJ. A.EckhoffD. E.Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice. Surgery136, 390–400 (2004).
8.
RytherR. C. C.FlyntA. S.PhilipsJ. A.PattonJ. G.siRNA therapeutics; big potential from small RNAs. Gene Therapy12, 5–11 (2005).
9.
TiscorniaG.SingerO.IkawaM.VernaI.A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA100, 1844–1848.
10.
UchidaH.TanakaT.SasakiK.KatoK.DehariH.ItoY.KobuneM.MiyagischiM.TairaK.TaharaH.HamadaH.Adeno-virus-mediated transfer of siRNA against surviving induced apoptosis and attenuated tumor cell growth in vitro andin vivo. Molecular Therapy10, 162–171 (2004).
11.
LehrmanS.Virus treatment questioned after gene therapy death. Nature401, 517–518 (1999).
12.
MarshallE.Gene therapy death prompts review of adenovirus vector. Science286, 2244–2245 (1999).
13.
Hacein-Bey-AbinaS.Von KalleC.SchmidtM.McCormackM. P.WulffraatN.LeboulchP.LimA.OsborneC. S.PawliukR.MorillonE.SorensenR.ForsterA.FraserP.CohenJ. I.de Saint BasileG.AlexanderI.WintergerstU.FrebourgT.AuriasA.Stoppa-LyonnetD.RomanaS.Radford-WeissI.GrossF.ValensiF.DelabesseE.MacintyreE.SigauxF.SoulierJ.LeivaL. E.WisslerM.PrinzC.RabbittsT. H.Le DeistF.FischerA.Cavazzana-CalvoM.LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science302, 415–419 (2003).
14.
Hacein-Bey-AbinaS.Von KalleC.SchmidtM.Le DeistF.WulffraatN.MacintyreE.RadfordI.VillevalJ. L.FraserP.Cavazzana-CalvoM.FischerA.A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. New England Journal of Medecine348, 255–256 (2003).
15.
CzaudernaF.SantelA.HinzM.DurieuxB.ArnoldW.KlippelA.KaufmannJ.Inductible shRNA expression for application in a prostate cancer mouse model. Nucleic Acids Research31, e127 (2003).
16.
IllC. R.ChiouH. C.Gene therapy progress and prospects: Recent progress in transgene and RNAi expression cassettes. Gene Therapy12, 795–802 (2005).
17.
ScherrK. J.MorganM. A.EderM.Gene silencing mediated by small interfering RNAs in mammalian cells. Current Medicinal Chemistry10, 245–256 (2003).
18.
WellsD. J.Gene therapy progress and prospects: Electroporation and other physical methods. Gene Therapy11, 1363–1369 (2004).
19.
VorhiesJ. S.NemunaitisJ.Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies. Expert Rev Anticancer Ther7, 373–382 (2007).
20.
GolzioM.RolsM. P.TeissieJ.In vitro and in vivo electric field-mediated permeabilization, gene transfer and expression. Methods32, 126–135.
21.
RolsM. P.DelteilC.GolzioM.DumondP.CrosS.TeissieJ.In vivo electrically mediated protein and gene transfer in murine melanoma. Nature Biotechnology16, 168–171 (1998).
22.
FariaM.SpillerD. G.DubertretC.NelsonJ. S.WhiteM. R.SchermanD.HeleneC.GiovannangeliC.Phosphoramidate oligonucleotides as potent antisense molecules in cells andin vivo. Nature Biotechnology19, 40–44 (2001).
23.
AiharaH.MiyazakiJ. I.Gene transfer into muscle by electroporationin vivo. Nature Biotechnology16, 867–870 (1998).
24.
MirL. M.BureauF. B.GehlJ.RangaraR.RouyD.CaillaudJ. M.DelaereP.BranellecD.SchwartzB.SchermanD.High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Sci USA96, 4262–4267 (1999).
25.
Pedron-MazoyerS.PlouëtJ.HellaudaisL.TeissieJ.GolzioM.New anti-angiogenesis developments through electro-immunization: Optimization by in vivo optical imaging of intradermal electrogenetransfer. Biochim Biophys Acta1770, 137–142 (2007).
26.
HellerR.JaroszeskiM.AtkinA.MoradpourD.GilbertR.WandsJ.NicolauC.In vivo gene electroinjection and expression in rat liver. FEBS Lett389, 225–228 (1996).
27.
PringleI. A.McLachlanG.CollieD. D.Sumner-JonesS. G.LawtonA. E.TennantP.BakerA.GordonC.BlundellR.VarathalingamA.DaviesL. A.SchmidR. A.ChengS. H.PorteousD. J.GillD. R.HydeS. C.Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung. J Gene Med9, 369–380 (2007).
28.
HarrisonR. L.ByrneB. J.TungL.Electroporation-mediated gene transfer in cardiac tissue. FEBS Lett435, 1–5 (1998).
29.
IsakaY.YamadaK.TakabatakeY.MizuiM.Miura-TsujieM.IchimaruN.YazawaK.UtsugiR.OkuyamaA.HoriM.ImaiE.TakaharaS.Electroporation-mediated HGF gene transfection protected the kidney against graft injury. Gene Therapy12, 815–820 (2005).
30.
KhouryM.BigeyP.Louis-PlenceP.NoelD.RhinnH.SchermanD.JorgensenC.ApparaillyF.A comparative study on intraarticular versus systemic gene electrotransfer in experimental arthritis. Gene Therapy8, 1027–1036 (2006).
31.
WangH.KoC. H.KoletarM. M.RalphM. R.YeomansJ.Casein kinase I epsilon gene transfer into the suprachiasmatic nucleus via electroporation lengthens circadian periods of tau mutant hamsters. Eur J Neuroscience25, 3359–3366 (2007).
32.
MatsudaT.CepkoC. L.Electroporation and RNA interference in the rodent retina in vivo andin vitro. Proc Natl Acad Sci USA101, 16–22 (2004).
33.
CemazarM.GolzioM.SersaG.RolsM. P.TeissiéJ.Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand?Current Pharmaceutical Design12, 3817–3825 (2006).
34.
HellerL. C.HellerR.In vivo electroporation for gene therapy. Hum Gene Ther17, 890–897 (2006).
35.
GolzioM.RolsM. P.GabrielB.TeissieJ.Optical imaging of in vivo gene expression: A critical assessment of the morphology and associated technologies. Gene Therapy11, S85–S91 (2004).
36.
YangM.BaranovE.LiX. M.WangJ. W.JiangP.LiL.MoossaA. R.PenmanS.HoffmanR. M.Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors. Proc Natl Acad Sci USA98, 2616–2621 (2001).
37.
BauerS.KirschningC. J.HackerH.RedeckeV.HausmannS.AkiraS.WagnerH.LipfordG. B.Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA98, 9237–9242 (2001).
38.
Chevalier-MarietteC.HenryI.MontfortL.CapgrasS.ForlaniS.MuschlerJ.NicolasJ. F.CpG content gene silencing in mice: Evidence from novel transgenes. Genome Biology4, R53 (2003).
39.
FaurieC.GolzioM.MollerP.TeissiéJ.RolsM. P.Cell and animal imaging of electrically mediated gene transfer. DNA Cell Biol22, 777–783 (2003).
40.
BogdanovA.WeisslederR.In vivo imaging of gene delivery and expression. Trends Biotechnology20, S11–S18 (2003).
41.
GolzioM.MazzoliniL.MollerP.RolsM. P.TeissiéJ.Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery. Gene Therapy12, 246–251 (2005).
42.
FireA.XuS.MontgomeryM. K.KostasS. A.DriverS. E.MelloC. C.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature391, 806–811 (1998).
43.
KimK. N.RNA interference in functional genomics and medicine. J Korean Med Sci18, 309–318 (2003).
44.
KishidaT.AsadaH.GojoS.OhashiS.Shin-YaM.YasutomiK.TerauchiR.TakahashiK. A.KuboT.ImanishiJ.MazdaO.Sequence-specific gene silencing in murine muscle induced by electroporation-mediated transfer of short interfering RNA. J Gene Med6, 105–110 (2004).
45.
EeftingD.GrimbergenJ. M.de VriesM. R.van WeelV.KaijzelE. L.QueI.MoonR. T.LöwikC. W.van BockelJ. H.QuaxP. H.Prolonged in vivo gene silencing by electroporation-mediated plasmid delivery of small interfering RNA. Human Gene Therapy18, 861–869 (2007).
46.
DurieuxA. C.BonnefoyR.FreyssenetD.Kinetic of transgene expression after electrotransfer into skeletal muscle: Importance of promoter origin/strength. Biochim Biophys Acta1725, 403–409 (2005).
47.
FabreE. E.BigeyP.OrsiniC.SchermanD.Comparison of promoter region constructs for in vivo intramuscular expression. J Gene Med8, 636–645 (2006).
48.
YewN. S.Controlling the kinetics of transgene expression by plasmid design. Adv Drug Deliv Rev57, 769–780 (2005).
DonàM.SandriM.RossiniK.Dell'AicaI.Podhorska-OkolowM.CarraroU.Functional in vivo gene transfer into the myofibers of adult skeletal muscle. Biochem Biophys Res Commun312, 1132–1138 (2003).
51.
DurieuxA. C.BonnefoyR.BussoT.FreyssenetD.In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage. J Gene Med6, 809–816 (2004).
52.
Leroy-WilligA.BureauM. F.SchermanD.CarlierP. G.In vivo NMR imaging evaluation of efficiency and toxicity of gene electrotransfer in rat muscle. Gene Ther12, 1434–1443 (2005).
53.
PatelK.AmthorH.The function of myostatin and strategies of myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle. Neuromuscular Disorders15, 117–126 (2005).
